Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial of Infliximab for Injection in Refractory Childhood Uveitis

NCT04150770 is registered in ClinicalTrials.gov with Xiaomin Zhang as lead sponsor.

NCT NCT04150770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04150770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial of Infliximab for Injection in Refractory Childhood Uveitis
Lead sponsor
Xiaomin Zhang
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2022
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infliximab, uveitis